The comparison between Beclomethason Dipropionate and Fluticasone Propionate in 6-16 year old patients with moderate asthma

The comparison between Beclomethason Dipropionate and Fluticasone Propionate in 6-17 year old patients with moderate asthma

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138812042976N2

Enrollment

Registered

2010-05-02

Start date

2007-12-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of inhaled corticosteroids (ICS) in moderate asthma. Asthma

Interventions

6-16 yrs old pations with moderate asthma.

Treatment - Drugs

6-16 yrs old pations with moderate asthma

Eligibility

Sex/Gender

All

Age

6 Years to 16 Years

Inclusion criteria

Inclusion criteria: Patients with symptoms of cough and wheezing at night and after exercise and FEV1 between 60-80% were included in the study. Patients with other known causes of wheezing such as cystic fibrosis and heart disorders were excluded from entry into study. None of patients had been receiving inhaled corticosteroids prior the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improvement of daily symptoms. Timepoint: weekly. Method of measurement: questionare.;Improvement of night symptoms. Timepoint: monthly. Method of measurement: questionare.;Reduction of rescue medication. Timepoint: monthly. Method of measurement: questionare.	—

Secondary

Measure	Time frame
Improvement of PFT. Timepoint: monthly. Method of measurement: spirometeric measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMogimi Haji Mohsen

Beheshti Hospital

moghimim m@yahoo.com+98 24 1413 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026